Veterinary Medicines

LYSVULPEN

Authorised
  • Rabies virus, strain SAD, Live
Download as PDF

Product identification

Medicine name:
LYSVULPEN
Active substance:
  • Rabies virus, strain SAD, Live
Target species:
  • Fox
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Rabies virus, strain SAD, Live
    6.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Fox
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07BD
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta, a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 130007
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 15/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."